Close Menu

NEW YORK (GenomeWeb) – Guardant Health this week opened its Asia, Middle East, and Africa headquarters in Singapore, which it said will scale commercialization of the firm's Guardant360 liquid biopsy assay in the region. It is currently offering the test to clinical customers in the region to assist with treatment selection for patients with advanced cancers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Associated Press reports that a state board in Texas has asked ANDE, a maker of rapid DNA machines, to halt its work there.

James Wyngaarden, the former director of the US National Institutes of Health, has died at 94, according to Duke University School of Medicine.

Researchers find that a 30-year-old skull comes from a narwhal-beluga hybrid, according to Science News.

In Nature this week: study of value diversity in GWAS, Epstein-Barr virus subtypes linked to nasopharyngeal carcinoma risk, and more.